Cagrilintide 2.5+Semaglutide 2.5mg 5mg

t is a dual blend totaling 5 mg of active ingredient, divided equally between semaglutide (2.5 mg) and cagrilintide (2.5 mg). While semaglutide regulates glucose and satiety through the GLP-1 receptor, cagrilintide acts as an amylin receptor agonist, further slowing gastric emptying and sending a complementary satiety signal to the brain. Together, they achieve significantly greater appetite reduction than either peptide alone.